CARRINGTON SUBSIDIARY GETS CHINESE PATENT FOR VACCINE TECH

Carrington Laboratories, Inc, a research-based biopharmaceutical and consumer products company, announced the issuance of Chinese Patent No. ZL 02807315.0 entitled "In Situ Gel Formation of Pectins" which relates to the company's proprietary GelSite polymer technology. The patent describes the use of pectin in situ gelling formulations for the delivery and sustained release of physiologically active agents such as drugs and vaccines. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34872§ionid=)